Wall Street Access Asset Management, LLC Gilead Sciences, Inc. Transaction History
Wall Street Access Asset Management, LLC
- $296 Million
- Q3 2025
A detailed history of Wall Street Access Asset Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wall Street Access Asset Management, LLC holds 418 shares of GILD stock, worth $51,869. This represents 0.02% of its overall portfolio holdings.
Number of Shares
418
Previous 8,080
94.83%
Holding current value
$51,869
Previous $895,000
94.86%
% of portfolio
0.02%
Previous 0.31%
Shares
37 transactions
Others Institutions Holding GILD
# of Institutions
2,368Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...